Quantcast Nektar Therapeutics Q3 Loss Narrows - Congoo
 
 
MARKETING Log In
Nektar Therapeutics Q3 Loss Narrows
Have an interest in this Story?
Sign Up for Real-Time email updates
RTTNews.com  | November 05, 2009

(RTTNews) - Nektar Therapeutics (NKTR: News ) posted third quarter net loss of $31.0 million or $0.33 per share, compared to a net loss of $37.0 million or $0.40 per share in the prior year quarter. On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.38 per...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Leo Petrik Leo Petrik
Founder & CEO
Entrepreneur
THENNY MEJIA THENNY MEJIA
Sr. Vice President
Healthcare Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.